The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125779872 12577987 2 F 20160514 20160830 20160721 20160906 EXP JP-ROCHE-1778062 ROCHE 69.43 YR M Y 64.00000 KG 20160906 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125779872 12577987 1 PS AVASTIN BEVACIZUMAB 1 Intravenous drip Y 125085 15 MG/KG Q3W
125779872 12577987 2 SS ERLOTINIB HYDROCHLORIDE. ERLOTINIB HYDROCHLORIDE 1 Oral Y 0 TABLET
125779872 12577987 3 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral 0 20 MG QD
125779872 12577987 4 C BAYASPIRIN ASPIRIN 1 Oral 0 100 MG QD
125779872 12577987 5 C TAKEPRON LANSOPRAZOLE 1 Oral 0 15 MG QD
125779872 12577987 6 C LOXOPROFEN LOXOPROFEN 1 Oral 0 60 MG QD
125779872 12577987 7 C NAIXAN NAPROXEN SODIUM 1 Oral 0 100 MG TID
125779872 12577987 8 C PANVITAN 2 Oral 0 1 G QD
125779872 12577987 9 C Baktar SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0 2 DF TABLET QD
125779872 12577987 10 C MAGMITT MAGNESIUM OXIDE 1 Oral 0 660 MG TID
125779872 12577987 11 C NOVORAPID INSULIN ASPART 1 Unknown 0
125779872 12577987 12 C GLACTIV SITAGLIPTIN 1 Oral 0 50 MG QD
125779872 12577987 13 C OPSO MORPHINE HYDROCHLORIDE 1 Unknown 0 10 MG
125779872 12577987 14 C PROMAC (JAPAN) 2 Oral 0 75 MG BID
125779872 12577987 15 C ALIMTA PEMETREXED DISODIUM 1 Intravenous drip 0 900 MG
125779872 12577987 16 C ALIMTA PEMETREXED DISODIUM 1 Unknown 0
125779872 12577987 17 C CARBOPLATIN. CARBOPLATIN 1 Intravenous drip 0 800 MG
125779872 12577987 18 C CARBOPLATIN. CARBOPLATIN 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125779872 12577987 1 Lung adenocarcinoma
125779872 12577987 2 Lung adenocarcinoma
125779872 12577987 3 Immune thrombocytopenic purpura
125779872 12577987 4 Acute myocardial infarction
125779872 12577987 5 Gastric ulcer
125779872 12577987 6 Cancer pain
125779872 12577987 7 Cancer pain
125779872 12577987 8 Prophylaxis
125779872 12577987 9 Prophylaxis
125779872 12577987 15 Lung adenocarcinoma
125779872 12577987 17 Lung adenocarcinoma

Outcome of event

Event ID CASEID OUTC COD
125779872 12577987 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125779872 12577987 Pneumatosis intestinalis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125779872 12577987 1 20160205 20160401 0
125779872 12577987 3 20150501 0
125779872 12577987 6 20151123 0
125779872 12577987 7 20151120 0
125779872 12577987 8 20151030 0
125779872 12577987 9 20150501 0
125779872 12577987 10 20151222 0
125779872 12577987 11 20150612 0
125779872 12577987 12 20150529 0
125779872 12577987 13 20160106 0
125779872 12577987 14 20160128 0
125779872 12577987 15 20160205 20160401 0
125779872 12577987 16 20151112 20160106 0
125779872 12577987 17 20160205 20160401 0
125779872 12577987 18 20151112 20160106 0